InventisBio Co

InventisBio Co Fixed Asset Turnover

Fixed Asset Turnover of InventisBio Co (688382.SS) as of Nov 11, 2026.

Fixed Asset Turnover

-

Last updated:

Fixed Asset Turnover of InventisBio Co is 2026 - . Fixed Asset Turnover of InventisBio Co was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

InventisBio Co Stock analysis

What does InventisBio Co do? InventisBio Co Ltd, headquartered in Shanghai, China, operates in the Health Care sector within the Biotechnology industry. The company employs 222 full-time staff and completed its IPO on July 25, 2022. InventisBio focuses on drug research and development for major diseases including tumors and metabolic conditions. Its core products under clinical development include D-0120, D-0502, D-1553, and BPI-D0316, targeting oncology and metabolic disease areas. InventisBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InventisBio Co stock

On Eulerpool you can find the complete historical development of Fixed Asset Turnover InventisBio Co since 2006 – with annual values, charts, and detailed analysis.

Fixed asset turnover measures revenue generated per unit of PP&E. Higher ratios indicate more efficient utilization of physical assets.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Fixed Asset Turnover's InventisBio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Fixed Asset Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Fixed Asset Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — InventisBio Co

All Key Metrics — InventisBio Co